The Susceptible-Infected-Recovered (SIR) model is a fundamental concept in epidemiology, offering insights into how diseases spread and recede in populations over time through a relatively simply set of functions. For
Author: Cody Micah Carmichael MPH, CPH
Top 5 Takeaways Significant Contribution by FRPP: The Federal Retail Pharmacy Program (FRPP) partners administered 67.7% of the 59.8 million COVID-19 bivalent vaccine doses in the U.S. during the study
Top 5 Takeaways Global Surveillance Enhancements: In 2022–2023, 71.4% of 28 priority countries met national acute flaccid paralysis (AFP) surveillance indicator targets, and environmental surveillance sites increased, supporting the global
Top 5 Takeaways Increased Heat Exposure and Illnesses: Maricopa and Yuma counties in Arizona saw an increase in heat exposure and heat-related illnesses (HRIs) from 2010 to 2020, with a
The Susceptible-Infected-Recovered (SIR) model is a fundamental concept in epidemiology, offering insights into how diseases spread and recede in populations over time through a relatively simply set of functions. For
Top 5 Takeaways Decline in HIV Testing and Diagnoses: From 2019 to 2020, there was a 17% decrease in new HIV diagnoses reported to the CDC, accompanying a significant decline
Person-years, often encountered in epidemiology and various forms of biomedical and public health research, stands as a pivotal concept that enables researchers to quantify the amount of time that study
Top 5 Takeaways Low Incidence of Severe Illness Post-Paxlovid: Hospitalizations or ED encounters for COVID-19 within 5-15 days after Paxlovid treatment were rare, occurring in <1% of patients, suggesting Paxlovid’s
Top 5 Takeaways Lagevrio and Paxlovid showed effectiveness in preventing hospitalization and death. These oral antiviral drugs have been crucial for patients with mild to moderate COVID-19 who are at
Top 5 Takeaways Significant number of pediatric hepatitis cases: From October 1, 2021, to June 15, 2022, 296 pediatric patients in the U.S. were diagnosed with hepatitis of unknown etiology,